The utility of the DDAVP challenge test in children with low von Willebrand factor.

The response of plasma von Willebrand factor to desmopressin (DDAVP) is related to the platelet levels of von Willebrand factor.

Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor.

Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content.

The association of factor VIII with von Willebrand factor.

Evaluation of a rapid von Willebrand factor activity latex immuno assay for monitoring of patients with von Willebrand disease (VWD) receiving DDAVP or VWF replacement therapy.

hemophilia A.

DDAVP-induced release of von Willebrand factor from endothelial cells in vitro: the effect of plasma and blood cells.

IIIa.

von Willebrand factor and the endothelium.

Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status.

von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.

Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.

von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease.

Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.

Von Willebrand factor and aging.

Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type III.

Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease.

Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.

von Willebrand factor in von Willebrand's disease.

Inhibition of Willebrand factor in von Willebrand disease.

Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII.

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.

Cirrhosis, von Willebrand Factor (vWF) and the Low Incidence of Metastatic Malignancy in Injured Liver.

Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.

Suggest Documents

The response of plasma von Willebrand factor to desmopressin (DDAVP) is related to the platelet levels of von Willebrand factor.

Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor.

Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content.

The association of factor VIII with von Willebrand factor.

Evaluation of a rapid von Willebrand factor activity latex immuno assay for monitoring of patients with von Willebrand disease (VWD) receiving DDAVP or VWF replacement therapy.

hemophilia A.

DDAVP-induced release of von Willebrand factor from endothelial cells in vitro: the effect of plasma and blood cells.

IIIa.

von Willebrand factor and the endothelium.

Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status.

von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.

Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.

von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease.

Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.

Von Willebrand factor and aging.

Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type III.

Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease.

Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.

von Willebrand factor in von Willebrand's disease.

Inhibition of Willebrand factor in von Willebrand disease.

Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII.

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.

Cirrhosis, von Willebrand Factor (vWF) and the Low Incidence of Metastatic Malignancy in Injured Liver.

Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.

The utility of the DDAVP challenge test in children with low von Willebrand factor.

Recommend Documents

Follow Us